← Open Payments lookup

MARIA CARDENAS: Open Payments

NPI 1700307337 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$690 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $74 · 2025 $690

Food & beverage: $588Education: $101
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$227
ABBVIE INC.6$120
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$117
Alkermes, Inc.3$51
Otsuka America Pharmaceutical, Inc.2$43
Lundbeck LLC2$39
Neurocrine BioSciences, Inc.1$23
Axsome Therapeutics, Inc.1$21
Vanda Pharmaceuticals Inc.1$20
Indivior Inc.1$15

Products named: VRAYLAR, CAPLYTA, REXULTI, UZEDY, AUSTEDO XR, ARISTADA, INGREZZA, VIVITROL.

Industry payments across CO — which companies pay providers there.